IMMUNE SUPPORT THIS SEASON-COLD and FLU

Seasonal occurrences of cold and flu are to be expected. Targeting the immune system during this time has the potential to help decrease the frequency, severity, or duration of cold and flu symptoms. Decreasing the risk of developing a cold or flu is possible through prophylactic supplementation, especially among high-risk populations, such as in children, the elderly, or those with compromised immune systems. In the event a cold or flu does occur, the desired focus of supplementation may shift to decreasing the duration and severity of symptoms. Zinc may be considered in this case; when given during the initial 24 hours of symptom onset, it has been shown to reduce the number of patients with symptoms after one week.1 Vitamin C is another popular remedy to decrease the length of a cold and has the potential to decrease duration by approximately half a day.2 The ingredients presented in the protocol below reflect research findings that demonstrate efficacy when used prophylactically and therapeutically to support physiological immune function in regards to cold and flu.
Vitamin C Adults: 1 g daily as an ongoing maintenance dose3,4, or 3 to 4 g daily at the onset of symptoms and for the duration of illness2,4 Children: 1 to 2 g daily as an ongoing maintenance dose4,2
Reduces the duration of the common cold by approximately a half-day2, or by 8% in adults and by 14-18% in children4
Reduces time of confinement by approximately six hours and fever duration by approximately a half-day, relieves chest pain and chills by approximately eight hours when given an extra therapeutic dose at the time of onset of cold2
Improves antimicrobial and natural killer (NK) cell activities, lymphocyte levels, chemotaxis, delayed T cell responses, sympathetic nervous response, and induces anti-reactive oxygen species activity2
Decreased duration of cold by 59% and increased weekly activity levels by 39.5% when compared to placebo in otherwise healthy adult males3
American ginseng (Panax quinquefolius)
400 mg, once per day, minimum 8-16 weeks in healthy adults as a preventative measure5,6,7
Reduces the duration of colds or acute respiratory infections by approximately 5-6 days5,7
Reduces the incidence of colds by 25%4, the incidence of influenza and respiratory syncytial virus, and the relative risk of respiratory symptoms by 48%6,8,7
Reduces total symptom severity score for sore throat, runny nose, sneezing, nasal congestion, malaise, fever, headache, hoarseness, earaches, and cough6
Zinc
75-100 mg of elemental zinc as zinc acetate or zinc gluconate lozenges, once per day, within 24 hours of the onset of common cold symptoms, minimum 1 to 2 weeks cold15,16,17,18,19
Reduces cold duration by 33%15, or by approximately 1.65 to 3 days in healthy adults cold16,17,18,20,21
Zinc acetate equivalently reduces the duration by 40% and zinc gluconate reduces the duration by 28%15, while other sources indicate greater efficacy with zinc acetate in healthy adults20
Reduces the incidence of cold symptoms after 5-7 days in healthy adults and children19,21
Reduces the duration of muscle soreness by 54%, cough by 46%, voice hoarseness by 43%, nasal congestion by 37%, nasal discharge by 34%, scratchy throat by 33%, sneezing by 22%, and sore throat by 18% in healthy adults19,21
Reduces the incidence of common cold development, absence from school, and antibiotic use in children1,17
Improves anti-inflammatory and antioxidant profile via reductions in plasma interleukin-1 receptor antagonist (IL-1ra), intercellular adhesion molecule-1 (ICAM-1), TNF-ɑ, MDA, HAE, and 8-oHdG, and increases in IL-2 mRNA in mononuclear cells in healthy adults21,22
Reduces duration of symptoms particularly when given within the first 24 hours of symptom onset1,23
Probiotics
Probiotics may reduce the incidence of colds with minor effects on prevention, as well as improve influenza vaccination efficacy for A/H1N1, A/H3N2, and B strains, but is dependent on strain and population.24,25,26
Pediatric:
Common Cold
5 billion CFU of Lactobacillus acidophilus NCFM (ATCC 700396), twice per day, minimum 6 months27
Reduces the incidence of fever by 53%, cough by 41%, and antibiotic use by 68%
Reduces the duration of fever, coughing, and rhinorrhea by 32%
Reduces days absent from childcare by 32%
Influenza
10 billion CFU of Bifidobacterium animalis subs. lactis Bi-07 (ATCC PTA-4802) & Lactobacillus acidophilus NCFM (ATCC 700396), twice per day for 6 months27
Reduces the incidence of fever by 73%, rhinorrhea by 73%, cough by 62%, and antibiotic use by 84%
Reduces the duration of fever, coughing, and rhinorrhea by 48%
Reduces days absent from childcare by 28%
Adult:
Common Cold
1 billion CFU of Lactobacillus paracasei 8700:2 (DSM 13434) & Lactobacillus plantarum HEAL 9 (DSM 15312), once per day for 3 months28
Reduces the incidence of developing more than one common cold episode and number of days with a cold
Reduces total symptom scores & pharyngeal symptoms of cold
Reduces B lymphocyte proliferation
Influenza
10 billion CFU of Lactobacillus fermentum CECT5716, once per day for 2 weeks before influenza vaccination and two weeks after29
Reduces the incidence of influenza 5-months after vaccination compared to vaccine alone
Increases natural killer cells, T-helper response, and IgA levels
10 billion CFU of Lactobacillus rhamnosus GG, twice per day for 4 weeks after influenza vaccination30
Increases seroprotection for the H3N2 strain during the supplementation period
500 mg of Saccharomyces cerevisiae (EpiCor®), once per day for 12 weeks31,32
Reduces the incidence of cold/flu symptoms with or without prior vaccination
Reduces the duration of symptoms with prior vaccination
References
1 A https://www.ncbi.nlm.nih.gov/pubmed/30069463
2 A https://www.ncbi.nlm.nih.gov/pubmed/23440782
3 A https://www.ncbi.nlm.nih.gov/pubmed/19592479
4 B https://www.ncbi.nlm.nih.gov/pubmed/16247099
5 C https://www.ncbi.nlm.nih.gov/pubmed/16566675
6 B https://www.ncbi.nlm.nih.gov/pubmed/14687309/
7 B https://www.ncbi.nlm.nih.gov/pubmed/23024696
8 A https://www.ncbi.nlm.nih.gov/pubmed/24554461
9 A https://www.ncbi.nlm.nih.gov/pubmed/16678640
10 A https://www.ncbi.nlm.nih.gov/pubmed/17597571
11 B https://www.ncbi.nlm.nih.gov/pubmed/14748902
12 C https://www.ncbi.nlm.nih.gov/pubmed/16177972
13 A https://www.ncbi.nlm.nih.gov/pubmed/28515951
14 A https://www.ncbi.nlm.nih.gov/pubmed/22566526
15 A https://www.ncbi.nlm.nih.gov/pubmed/27378206
16 A https://www.ncbi.nlm.nih.gov/pubmed/23775705
17 A https://www.ncbi.nlm.nih.gov/pubmed/28480298
18 A https://www.ncbi.nlm.nih.gov/pubmed/25888289
19 B https://www.ncbi.nlm.nih.gov/pubmed/18279051
20 B https://www.ncbi.nlm.nih.gov/pubmed/17344507
21 A https://www.ncbi.nlm.nih.gov/pubmed/23372900
22 A https://www.ncbi.nlm.nih.gov/pubmed/29416317
23 A https://www.ncbi.nlm.nih.gov/pubmed/29077061
24 B https://www.ncbi.nlm.nih.gov/pubmed/19651563
25 B https://www.ncbi.nlm.nih.gov/pubmed/20803023
26 B https://www.ncbi.nlm.nih.gov/pubmed/17352961
27 C https://www.ncbi.nlm.nih.gov/pubmed/21285968